0000899243-23-012066.txt : 20230503
0000899243-23-012066.hdr.sgml : 20230503
20230503151710
ACCESSION NUMBER: 0000899243-23-012066
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230421
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCarthy Christopher
CENTRAL INDEX KEY: 0001975031
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24249
FILM NUMBER: 23883319
MAIL ADDRESS:
STREET 1: C/O INTERPACE BIOSCIENCES, INC.
STREET 2: 300 INTERPACE PARKWAY; BLDG C, 1ST FLOOR
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERPACE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001054102
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 222919486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 412-224-6100
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Interpace Diagnostics Group, Inc.
DATE OF NAME CHANGE: 20151223
FORMER COMPANY:
FORMER CONFORMED NAME: PDI INC
DATE OF NAME CHANGE: 20021113
FORMER COMPANY:
FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC
DATE OF NAME CHANGE: 19980129
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-04-21
0
0001054102
INTERPACE BIOSCIENCES, INC.
IDXG
0001975031
McCarthy Christopher
C/O INTERPACE BIOSCIENCES, INC.
300 INTERPACE PARKWAY; BLDG C, 1ST FLOOR
PARSIPPANY
NJ
07054
0
1
0
0
Principal Financial Officer
Common Stock
7310
D
Stock Option (right to buy)
6.00
2031-03-10
Common Stock
2500
D
Restricted Stock Units
0.00
Common Stock
5000
D
One-third of the options will vest and become exercisable on 3/10/2022, and the remaining portion will vest and become exercisable in 24 equal monthly installments commencing on the first day of April 2022, subject to continued employment through each such vesting date.
One-third of the restricted stock units will vest commencing on December 1, 2022 and the remaining two-thirds will vest in equal yearly installments thereafter for the next two years.
/s/ Christopher McCarthy
2023-05-03